|
Originally published In Press as doi:10.1074/jbc.M001615200 on April 7, 2000
J. Biol. Chem., Vol. 275, Issue 25, 18664-18669, June 23, 2000
Species-specific Alternative Splice Mimicry at the Growth Hormone
Receptor Locus Revealed by the Lineage of Retroelements during Primate
Evolution
A NOVEL MECHANISM ACCOUNTING FOR PROTEIN DIVERSITY BETWEEN AND
WITHIN SPECIES*
Jacques
Pantel §,
Kalotina
Machinis ,
Marie-Laure
Sobrier,
Philippe
Duquesnoy,
Michel
Goossens, and
Serge
Amselem¶
From the Institut National de la Santé et de la Recherche
Médicale, Unité 468, Hôpital Henri Mondor,
94010 Créteil Cedex, France
In humans, growth hormone receptor (GHR)
transcripts exist in two isoforms differing by the retention (GHRfl) or
exclusion (GHRd3) of exon 3, whereas in mice GHRfl is solely expressed. This species-specific expression pattern is believed to result from an
alternative splice event that, on the basis of conflicting data
obtained in humans, has been considered to be tissue-, developmentally, and/or individual-specific. To decipher the molecular basis of this
unusual trait, we isolated a 6.8-kilobase fragment spanning exon 3 from
individuals expressing GHRfl. Sequence analysis revealed the existence
of two 99% identical retroelements flanking this exon. Unexpectedly,
individuals expressing GHRd3 displayed a 2.7-kilobase deletion
involving exon 3, which most likely results from an ancestral homologous recombination between the two retroelements. The lineage of
these retroelements during primate evolution revealed the species specificity of the GHRd3 allele. These findings led us to propose a
model underlying the existence of the sole GHRfl allele in most species. Such a retrovirus-mediated alternative splice mimicry, which
clears up several as yet unexplained phenomena (i.e. the above-mentioned expression data, the Mendelian inheritance of GHR
expression patterns, and the deletion of nonconsecutive exons in
growth hormone resistant patients), represents a novel
physiological mechanism accounting for protein diversity between and
within species.
*
This work was supported by an institutional grant from the
INSERM.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF155912, AF210633, AF209078-209083, and
AF211184-211186.
These authors contributed equally to this work.
§
Recipient of a fellowship from the Institut National de la
Santé et de la Recherche Médicale.
¶
To whom correspondence should be addressed. E-mail:
amselem@ im3.inserm.fr.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Bianchi, A. Giustina, V. Cimino, R. Pola, F. Angelini, A. Pontecorvi, and L. De Marinis
Influence of Growth Hormone Receptor d3 and Full-Length Isoforms on Biochemical Treatment Outcomes in Acromegaly
J. Clin. Endocrinol. Metab.,
June 1, 2009;
94(6):
2015 - 2022.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. L. Barbosa, J. Palming, C. A. M. Glad, H. Filipsson, J. Koranyi, B.-A. Bengtsson, L. M. S. Carlsson, C. L. Boguszewski, and G. Johannsson
Influence of the Exon 3-Deleted/Full-Length Growth Hormone (GH) Receptor Polymorphism on the Response to GH Replacement Therapy in Adults with Severe GH Deficiency
J. Clin. Endocrinol. Metab.,
February 1, 2009;
94(2):
639 - 644.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mercado, B. Gonzalez, C. Sandoval, Y. Esquenazi, F. Mier, G. Vargas, A. L. E. de los Monteros, and E. Sosa
Clinical and Biochemical Impact of the d3 Growth Hormone Receptor Genotype in Acromegaly
J. Clin. Endocrinol. Metab.,
September 1, 2008;
93(9):
3411 - 3415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Kenth, J. A M. Mergelas, and C. G. Goodyer
Developmental changes in the human GH receptor and its signal transduction pathways
J. Endocrinol.,
July 1, 2008;
198(1):
71 - 82.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. van der Klaauw, T. van der Straaten, R. Baak-Pablo, N. R. Biermasz, H.-J. Guchelaar, A. M. Pereira, J. W. A. Smit, and J. A. Romijn
Influence of the d3-Growth Hormone (GH) Receptor Isoform on Short-Term and Long-Term Treatment Response to GH Replacement in GH-Deficient Adults
J. Clin. Endocrinol. Metab.,
July 1, 2008;
93(7):
2828 - 2834.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Audi, A. Carrascosa, C. Esteban, M. Fernandez-Cancio, P. Andaluz, D. Yeste, R. Espadero, M. L. Granada, H. Wollmann, L. Fryklund, et al.
The exon 3-deleted/full-length Growth Hormone Receptor Polymorphism Does Not Influence the Effect of Puberty or Growth Hormone Therapy on Glucose Homeostasis in Short Non-Growth Hormone-Deficient Small-for-Gestational-Age Children: Results from a Two-Year Controlled Prospective Study
J. Clin. Endocrinol. Metab.,
July 1, 2008;
93(7):
2709 - 2715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Cao, H. Lu, J. Feng, J. Shu, D. Zheng, and Y. Hou
Lung Cancer Risk Associated with Thr495Pro Polymorphism of GHR in Chinese Population
Jpn. J. Clin. Oncol.,
April 1, 2008;
38(4):
308 - 316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Raz, M. Janner, V. Petkovic, D. Lochmatter, A. Eble, M. T. Dattani, P. C. Hindmarsh, C. E. Fluck, and P. E. Mullis
Influence of Growth Hormone (GH) Receptor Deletion of Exon 3 and Full-Length Isoforms on GH Response and Final Height in Patients with Severe GH Deficiency
J. Clin. Endocrinol. Metab.,
March 1, 2008;
93(3):
974 - 980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Carrascosa, L. Audi, M. Fernandez-Cancio, C. Esteban, P. Andaluz, E. Vilaro, M. Clemente, D. Yeste, M. A. Albisu, and M. Gussinye
The Exon 3-Deleted/Full-Length Growth Hormone Receptor Polymorphism Did Not Influence Growth Response to Growth Hormone Therapy over Two Years in Prepubertal Short Children Born at Term with Adequate Weight and Length for Gestational Age
J. Clin. Endocrinol. Metab.,
March 1, 2008;
93(3):
764 - 770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Carrascosa, L. Audi, C. Esteban, M. Fernandez-Cancio, P. Andaluz, M. Gussinye, M. Clemente, D. Yeste, and M. A. Albisu
Growth Hormone (GH) Dose, But Not Exon 3-Deleted/Full-Length GH Receptor Polymorphism Genotypes, Influences Growth Response to Two-Year GH Therapy in Short Small-for-Gestational-Age Children
J. Clin. Endocrinol. Metab.,
January 1, 2008;
93(1):
147 - 153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Schreiner, S. Stutte, P. Bartmann, B. Gohlke, and J. Woelfle
Association of the Growth Hormone Receptor d3-Variant and Catch-up Growth of Preterm Infants with Birth Weight of Less Than 1500 Grams
J. Clin. Endocrinol. Metab.,
November 1, 2007;
92(11):
4489 - 4493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schmid, P.-A. Krayenbuehl, R.-L. Bernays, C. Zwimpfer, F. E. Maly, and P. Wiesli
Growth Hormone (GH) Receptor Isoform in Acromegaly: Lower Concentrations of GH but Not Insulin-Like Growth Factor-1 in Patients with a Genomic Deletion of Exon 3 in the GH Receptor Gene
Clin. Chem.,
August 1, 2007;
53(8):
1484 - 1488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Jensen, S. Vielwerth, T. Larsen, G. Greisen, H. Leffers, and A. Juul
The Presence of the d3-Growth Hormone Receptor Polymorphism Is Negatively Associated with Fetal Growth but Positively Associated with Postnatal Growth in Healthy Subjects
J. Clin. Endocrinol. Metab.,
July 1, 2007;
92(7):
2758 - 2763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Fang, S. Riedl, S. Amselem, K. L. Pratt, B. M. Little, G. Haeusler, V. Hwa, H. Frisch, and R. G. Rosenfeld
Primary Growth Hormone (GH) Insensitivity and Insulin-Like Growth Factor Deficiency Caused by Novel Compound Heterozygous Mutations of the GH Receptor Gene: Genetic and Functional Studies of Simple and Compound Heterozygous States
J. Clin. Endocrinol. Metab.,
June 1, 2007;
92(6):
2223 - 2231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Kenth, Z. Shao, D. E. C. Cole, and C. G. Goodyer
Relationship of the Human Growth Hormone Receptor Exon 3 Genotype with Final Adult Height and Bone Mineral Density
J. Clin. Endocrinol. Metab.,
February 1, 2007;
92(2):
725 - 728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. McKay, R. Kaaks, M. Johansson, C. Biessy, F. Wiklund, K. Balter, H.-O. Adami, C. Boillot, L. Gioia-Patricola, F. Canzian, et al.
Haplotype-Based Analysis of Common Variation in the Growth Hormone Receptor Gene and Prostate Cancer Risk
Cancer Epidemiol. Biomarkers Prev.,
January 1, 2007;
16(1):
169 - 173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Audi, C. Esteban, A. Carrascosa, R. Espadero, A. Perez-Arroyo, R. Arjona, M. Clemente, H. Wollmann, L. Fryklund, L. A. Parodi, et al.
Exon 3-Deleted/Full-Length Growth Hormone Receptor Polymorphism Genotype Frequencies in Spanish Short Small-for-Gestational-Age (SGA) Children and Adolescents (n = 247) and in an Adult Control Population (n = 289) Show Increased fl/fl in Short SGA
J. Clin. Endocrinol. Metab.,
December 1, 2006;
91(12):
5038 - 5043.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Pfaffle
Genetics of growth in the normal child
Eur. J. Endocrinol.,
November 1, 2006;
155(suppl_1):
S27 - S33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. F. Blum, K. Machinis, E. P. Shavrikova, A. Keller, H. Stobbe, R. W. Pfaeffle, and S. Amselem
The Growth Response to Growth Hormone (GH) Treatment in Children with Isolated GH Deficiency Is Independent of the Presence of the Exon 3-Minus Isoform of the GH Receptor
J. Clin. Endocrinol. Metab.,
October 1, 2006;
91(10):
4171 - 4174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Carrascosa, C. Esteban, R. Espadero, M. Fernandez-Cancio, P. Andaluz, M. Clemente, L. Audi, H. Wollmann, L. Fryklund, L. Parodi, et al.
The d3/fl-Growth Hormone (GH) Receptor Polymorphism Does Not Influence the Effect of GH Treatment (66 {micro}g/kg per Day) or the Spontaneous Growth in Short Non-GH-Deficient Small-for-Gestational-Age Children: Results from a Two-Year Controlled Prospective Study in 170 Spanish Patients
J. Clin. Endocrinol. Metab.,
September 1, 2006;
91(9):
3281 - 3286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Asher and M. Hofreiter
Tenrec Phylogeny and the Noninvasive Extraction of Nuclear DNA
Syst Biol,
April 1, 2006;
55(2):
181 - 194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Rosenfeld
The Pharmacogenomics of Human Growth.
J. Clin. Endocrinol. Metab.,
March 1, 2006;
91(3):
795 - 796.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. L. Jorge, F. G. Marchisotti, L. R. Montenegro, L. R. Carvalho, B. B. Mendonca, and I. J. P. Arnhold
Growth Hormone (GH) Pharmacogenetics: Influence of GH Receptor Exon 3 Retention or Deletion on First-Year Growth Response and Final Height in Patients with Severe GH Deficiency
J. Clin. Endocrinol. Metab.,
March 1, 2006;
91(3):
1076 - 1080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Binder, F. Baur, R. Schweizer, and M. B. Ranke
The d3-Growth Hormone (GH) Receptor Polymorphism Is Associated with Increased Responsiveness to GH in Turner Syndrome and Short Small-for-Gestational-Age Children
J. Clin. Endocrinol. Metab.,
February 1, 2006;
91(2):
659 - 664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. N. Nurtdinov, I. I. Artamonova, A. A. Mironov, and M. S. Gelfand
Low conservation of alternative splicing patterns in the human and mouse genomes
Hum. Mol. Genet.,
June 1, 2003;
12(11):
1313 - 1320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Pantel, J. Grulich-Henn, M. Bettendorf, C. J. Strasburger, U. Heinrich, and S. Amselem
Heterozygous Nonsense Mutation in Exon 3 of the Growth Hormone Receptor (GHR) in Severe GH Insensitivity (Laron Syndrome) and the Issue of the Origin and Function of the GHRd3 Isoform
J. Clin. Endocrinol. Metab.,
April 1, 2003;
88(4):
1705 - 1710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gebre-Medhin, L.-G. Kindblom, H. Wennbo, J. Tornell, and J. M. Meis-Kindblom
Growth Hormone Receptor Is Expressed in Human Breast Cancer
Am. J. Pathol.,
April 1, 2001;
158(4):
1217 - 1222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Papin, P. Duquesnoy, C. Cazeneuve, J. Pantel, M. Coppey-Moisan, C. Dargemont, and S. Amselem
Alternative splicing at the MEFV locus involved in familial Mediterranean fever regulates translocation of the marenostrin/pyrin protein to the nucleus
Hum. Mol. Genet.,
December 1, 2000;
9(20):
3001 - 3009.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|